I
555.80
-4.56 (-0.81%)
| 前收盘价格 | 560.36 |
| 收盘价格 | 559.28 |
| 成交量 | 496,988 |
| 平均成交量 (3个月) | 546,512 |
| 市值 | 43,786,547,200 |
| 市盈率 (P/E TTM) | 39.06 |
| 预期市盈率 (P/E Forward) | 31.45 |
| 价格/销量 (P/S) | 9.18 |
| 股市价格/股市净资产 (P/B) | 25.48 |
| 52周波幅 | |
| 利润日期 | 2 Nov 2026 |
| 营业毛利率 | 22.76% |
| 营业利益率 (TTM) | 31.70% |
| 稀释每股收益 (EPS TTM) | 10.82 |
| 季度收入增长率 (YOY) | 3.60% |
| 季度盈利增长率 (YOY) | 3.00% |
| 总债务/股东权益 (D/E MRQ) | 73.16% |
| 流动比率 (MRQ) | 1.16 |
| 营业现金流 (OCF TTM) | 968.38 M |
| 杠杆自由现金流 (LFCF TTM) | 761.15 M |
| 资产报酬率 (ROA TTM) | 22.98% |
| 股东权益报酬率 (ROE TTM) | 59.33% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 看涨 |
| Diagnostics & Research (全球的) | 混合的 | 看涨 | |
| 股票 | IDEXX Laboratories, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
0.3
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -1.0 |
| 技术平均移动指标 | 1.5 |
| 技术振荡指标 | 2.0 |
| 相对估值 | -5.0 |
| 财务健康 | 2.5 |
| AI Insight | NA |
| 平均 | 0.31 |
|
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Mid Growth |
| 内部持股比例 | 0.67% |
| 机构持股比例 | 97.51% |
该时间范围内无数据。
该时间范围内无数据。
AI 技术分析
打开“技术”标签以生成最新分析。
投资组合